01—Abstract
Summary
Summary of the 8-K filed April 22, 2026. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. (CME) has filed an 8-K report on April 22, 2026, primarily to disclose its financial results for the quarter ended March 31, 2026, through an attached press release (Exhibit 99.1).
The report emphasizes that the information contained within the press release, including financial results, is not deemed "filed" under SEC regulations but is provided for informational purposes. Investors should note that while GAAP-based financial statements are available, the press release also includes non-GAAP financial measures such as revenues, expenses, operating income, net income, and earnings per share. Management of CME Group asserts that these non-GAAP measures offer valuable supplemental information for assessing financial and business trends and provide a better basis for comparison with prior periods.
While these non-GAAP figures are presented as a supplement to GAAP results and are reconciled within the press release as required by Regulation G, investors are advised to consider them alongside, and not as a replacement for, the official GAAP financial statements. The filing also includes an Inline XBRL cover page as Exhibit 104.
02—Key points
Key Highlights
- CME Group Inc. released its financial results for the quarter ended March 31, 2026, via an 8-K filing on April 22, 2026.
- The financial results are primarily presented in an attached press release (Exhibit 99.1).
- The press release includes both GAAP and non-GAAP financial measures.
- Non-GAAP financial measures include revenues, expenses, operating income, net income, and earnings per share.
- Management believes non-GAAP measures provide useful supplemental information for trend analysis and comparability.
- Reconciliation of non-GAAP to GAAP measures is provided in the press release per Regulation G requirements.
- Information in the press release is not considered "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
03—Questions
Frequently Asked Questions
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report CME Group Inc.'s financial results for the quarter ended March 31, 2026, through an accompanying press release (Exhibit 99.1).
Does the filing contain both GAAP and non-GAAP financial information?
Yes, the attached press release includes both financial measures prepared in accordance with Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures, such as non-GAAP revenues, net income, and earnings per share.
Why does CME Group provide non-GAAP financial measures?
CME Group's management believes that non-GAAP financial measures provide important supplemental information that helps management and investors understand financial and business trends, and allows for better comparability with the company's prior financial reports.
How should investors interpret the non-GAAP financial information?
Investors should view the non-GAAP financial measures as a supplement to, and not a substitute for, the corresponding GAAP financial measures. The press release contains a reconciliation of these non-GAAP measures to the most directly comparable GAAP measures.
04—Continue